Viewing Study NCT00059904


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-25 @ 6:59 PM
Study NCT ID: NCT00059904
Status: COMPLETED
Last Update Posted: 2013-07-18
First Post: 2003-05-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module